Evidence map›Paper›PMID 35062865›Full record

ArticleBMC genomics2022

Genome insights into the pharmaceutical and plant growth promoting features of the novel species Nocardia alni sp. nov.

Imen Nouioui, Sung-Min Ha, Inwoo Baek, Jongsik Chun, Michael Goodfellow

Open access · goldAbstract read
In one paragraph

Article in BMC genomics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
15.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. The genus Nocardia as a source of new antimicrobials.npj antimicrobials and resistance · 2025
    Review
  8. Article
  9. Pitting the olive seed microbiome.Environmental microbiome · 2024
    Article
  10. Article
  11. Review
  12. A Complete Genome ofInfection and drug resistance · 2022
    Article
  13. Root Nodule Microsymbionts of NativeMicrobiology insights · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 4 countries.

Imen NouiouiDepartment of Microorganisms, Leibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures, 38124, Braunschweig, Germany. imen.nouioui@dsmz.de.
Sung-Min HaDepartment of Integrative Biology and Physiology, University of California Los Angeles, 610 Charles E. Young Drive East, Los Angeles, CA 90095, USA.
Inwoo BaekSchool of Biological Sciences & Institute of Molecular Biology and Genetics, Seoul National University, Seoul, Korea.
Jongsik ChunSchool of Biological Sciences & Institute of Molecular Biology and Genetics, Seoul National University, Seoul, Korea.
Michael GoodfellowSchool of Natural and Environmental Sciences, Newcastle University, Ridley Building 2, NE1 7RU, Newcastle upon Tyne, UK.
Seoul National University · KRLeibniz Institute DSMZ – German Collection of Microorganisms and Cell Cultures · DENewcastle University · GBUniversity of California, Los Angeles · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecent studies highlighted the biosynthetic potential of nocardiae to produce diverse novel natural products comparable to that of Streptomyces, thereby making them an attractive source of new drug leads. Many of the 119 Nocardia validly named species were isolated from natural habitats but little is known about the diversity and the potential of the endophytic nocardiae of root nodule of actinorhizal plants.

resultsThe taxonomic status of an actinobacterium strain, designated ncl2

conclusionsOur genome-based taxonomic study showed that isolate ncl2

Indexed as

Pharmaceutical PreparationsSoil MicrobiologyBacterial Typing TechniquesBase CompositionDNA, BacterialFatty AcidsFrankiaNucleic Acid HybridizationPhylogenyRNA, Ribosomal, 16SSequence Analysis, DNADNA, BacterialFatty AcidsPharmaceutical PreparationsRNA, Ribosomal, 16SGenome miningPlant growth promoting propertiesPolyphasic taxonomyPutatively novel antibiotics

Identifiers

PMID35062865
PMCPMC8783487
OpenAlexW4206953582

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.